• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Rosie Riley, USA

      Rosie Riley, USA

    • Mikey Stone, ALS

      Mikey Stone, ALS

    • Oliver Juenke, Germany

      Oliver Juenke, Germany

    • Fernando Ocampo Cardona, Colombia

      Fernando Ocampo Cardona, Colombia

    • Lucy Lintott, Scotland

      Lucy Lintott, Scotland

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Magdalena Ayala Rodríguez, Mexico

      Magdalena Ayala Rodríguez, Mexico

    • Brian Lovell, Australia

      Brian Lovell, Australia

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Cath Muir, UK

      Cath Muir, UK
      Cath

    • Mike Cels, Canada

      Mike Cels, Canada

    • Mahmood Anwar, UK

      Mahmood Anwar, UK

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Natalya Rybakova, Russia

      Natalya Rybakova, Russia

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Colm Francis Davis, Ireland

      Colm Francis Davis, Ireland

    • Bob Spurrier, USA

      Bob Spurrier, USA

    • Verónica Isabel Castro Molina, Argentina

      Verónica Isabel Castro Molina, Argentina

    • Elkin Ramiro Gaviria Muñoz, Colombia

      Elkin Ramiro Gaviria Muñoz, Colombia

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • Glen Victor Peters, Australia

      Glen Victor Peters, Australia

    • Greg Heydet, USA

      Greg Heydet, USA

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • Purningam Jacob, India

      Purningam Jacob, India

    • Patrick Shuma, Kenya

      Patrick Shuma, Kenya

    • Dawn Morton, Scotland

      Dawn Morton, Scotland

    • Olga, Argentina

      Olga, Argentina

    • Xian-Zhang Niu, China

      Xian-Zhang Niu, China

    • Dan Doctoroff, USA

      Dan Doctoroff, USA

    • Zelina Brito, Brazil

      Zelina Brito, Brazil

    • Chris McCauley, Canada

      Chris McCauley, Canada

    • Anna Barrow, UK

      Anna Barrow, UK

    • Margarita Pizarro, Argentina

      Margarita Pizarro, Argentina

    • Ana Lilia Rodriguez, Mexico

      Ana Lilia Rodriguez, Mexico

    • Nicholas (Nic) Bowman, South Africa

      Nicholas (Nic) Bowman, South Africa

    • Claire Garry, USA

      Claire Garry, USA
      20200117_214643

    • Josée Kolijn-de Man, Netherlands

      Josée Kolijn-de Man, Netherlands

    • Ian Gale, Australia

      Ian Gale, Australia

    • Bayley, Australia

      Bayley, Australia

    • Eddy LeFrançois, Canada

      Eddy LeFrançois, Canada

    • Susan Anderson, USA

      Susan Anderson, USA

    • Claudia Cominetti, Italy

      Claudia Cominetti, Italy

    • Torben Mikkelsen, Denmark

      Torben Mikkelsen, Denmark

    • Timothy Holman, Switzerland

      Timothy Holman, Switzerland

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login